Latest news 17th March 2026 Cancer Research UK and NovalGen dose the first patient in the Phase 1 trial of T-cell engager NVG-222 17th September 2025 NovalGen to Begin World’s First Clinical Trial for a Self-Regulating Immunotherapy VIEW ALL NEWS Publications Read our publications here VIEW ALL PUBLICATIONS
17th March 2026 Cancer Research UK and NovalGen dose the first patient in the Phase 1 trial of T-cell engager NVG-222
17th September 2025 NovalGen to Begin World’s First Clinical Trial for a Self-Regulating Immunotherapy
